Trexquant Investment’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-112,464	Closed	-$2.29M	–	1628
2025 Q2	$2.29M	Buy	112,464 +34,254	+44%	+$667K	0.03%	841
2025 Q1	$1.42M	Buy	+78,210	New	+$1.75M	0.02%	977
2024 Q3	–	Sell	-12,092	Closed	-$448K	–	1561
2024 Q2	$448K	Sell	12,092 -75,930	-86%	-$2.86M	0.01%	1279
2024 Q1	$3.69M	Buy	88,022 +56,593	+180%	+$2.32M	0.07%	417
2023 Q4	$1.25M	Buy	+31,429	New	+$924K	0.03%	743
2022 Q4	–	Sell	-13,316	Closed	-$374K	–	1405
2022 Q3	$374K	Buy	+13,316	New	+$408K	0.01%	932
2022 Q1	–	Sell	-8,889	Closed	-$343K	–	1397
2021 Q4	$343K	Buy	8,889 +1,680	+23%	+$73.2K	0.02%	846
2021 Q3	$389K	Buy	+7,209	New	+$338K	0.03%	635
2015 Q4	–	Sell	-14,006	Closed	-$2.21M	–	1042
2015 Q3	$2.21M	Buy	14,006 +11,746	+520%	+$3.32M	0.19%	129
2015 Q2	$854K	Sell	2,260 -3,513	-61%	-$1.4M	0.1%	391
2015 Q1	$2.41M	Buy	5,773 +1,629	+39%	+$583K	0.25%	60
2014 Q4	$1.13M	Buy	+4,144	New	+$1.03M	0.2%	114